The DOI matches its Crossref record; 177 of the 177 references it cites were found in a registry or an index.
Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles
Open accessAbstract
Nanoparticle drug delivery to the tumor is impacted by multiple factors: nanoparticles must evade clearance by renal filtration and the reticuloendothelial system, extravasate through the enlarged endothelial gaps in tumors, penetrate through dense stroma in the tumor microenvironment to reach the tumor cells, remain in the tumor tissue for a prolonged period of time, and finally release the active agent to induce pharmacological effect. The physicochemical properties of nanoparticles such as size, shape, surface charge, surface chemistry (PEGylation, ligand conjugation) and composition affect the pharmacokinetics, biodistribution, intratumoral penetration and tumor bioavailability. On the other hand, tumor biology (blood flow, perfusion, permeability, interstitial fluid pressure and stroma content) and patient characteristics (age, gender, tumor type, tumor location, body composition and prior treatments) also have impact on drug delivery by nanoparticles. It is now believed that both nanoparticles and the tumor microenvironment have to be optimized or adjusted for optimal delivery. This review provides a comprehensive summary of how these nanoparticle and biological factors impact nanoparticle delivery to tumors, with discussion on how the tumor microenvironment can be adjusted and how patients can be stratified by imaging methods to receive the maximal benefit of nanomedicine. Perspectives and future directions are also provided.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Angiogenesis in cancer and other diseases
Carmeliet, P., & Jain, R. K. (2000) · Nature · doi:10.1038/35025220 · Cited by 9,070
Determining the Size and Shape Dependence of Gold Nanoparticle Uptake into Mammalian Cells
Chithrani, B. D., Ghazani, A. A., & Chan, W. C. W. (2006) · Nano Letters · doi:10.1021/nl052396o · Cited by 4,879
Liposomal drug delivery systems: From concept to clinical applications
Allen, T. M., & Cullis, P. R. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.037 · Cited by 4,839
Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538
Renal clearance of quantum dots
Soo Choi, H., Liu, W., Misra, P., Tanaka, E., Zimmer, J. P., Itty Ipe, B., Bawendi, M. G., & Frangioni, J. V. (2007) · Nature Biotechnology · doi:10.1038/nbt1340 · Cited by 4,476
Tumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391 · cited 2×
“immune cells, and extracellular matrix (ECM), which are collectively termed stroma, and is the dominant fraction of the total tumor mass [104, 105].”
BackgroundRegulated portals of entry into the cell
Conner, S. D., & Schmid, S. L. (2003) · Nature · doi:10.1038/nature01451 · Cited by 3,805
Factors affecting the clearance and biodistribution of polymeric nanoparticles
Alexis, F., Pridgen, E., Molnar, L. K., & Farokhzad, O. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800051m · Cited by 3,699
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles
OWENSIII, D., & PEPPAS, N. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.010 · Cited by 3,637
Fang, J., Nakamura, H., & Maeda, H. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.04.009 · Cited by 3,559
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01494-7 · Cited by 3,515
Delivering nanomedicine to solid tumors
Jain, R. K., & Stylianopoulos, T. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.139 · Cited by 3,180
Olive, K. P., Jacobetz, M. A., Davidson, C. J., Gopinathan, A., McIntyre, D., Honess, D., Madhu, B., Goldgraben, M. A., Caldwell, M. E., Allard, D., et al. (2009) · Science · doi:10.1126/science.1171362 · Cited by 3,170
The effect of particle design on cellular internalization pathways
Gratton, S. E. A., Ropp, P. A., Pohlhaus, P. D., Luft, J. C., Madden, V. J., Napier, M. E., & DeSimone, J. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801763105 · Cited by 2,918
Nanoparticle-mediated cellular response is size-dependent
Jiang, W., Kim, B. Y. S., Rutka, J. T., & Chan, W. C. W. (2008) · Nature Nanotechnology · doi:10.1038/nnano.2008.30 · Cited by 2,776
Shape effects of filaments versus spherical particles in flow and drug delivery
Geng, Y., Dalhaimer, P., Cai, S., Tsai, R., Tewari, M., Minko, T., & Discher, D. E. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.70 · Cited by 2,565
Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size
Cabral, H., Matsumoto, Y., Mizuno, K., Chen, Q., Murakami, M., Kimura, M., Terada, Y., Kano, M. R., Miyazono, K., Uesaka, M., et al. (2011) · Nature Nanotechnology · doi:10.1038/nnano.2011.166 · Cited by 2,429
Self-citationMaeda, H., Nakamura, H., & Fang, J. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.10.002 · Cited by 2,376
High Interstitial Fluid Pressure - an Obstacle in Cancer Therapy
Heldin, C.-H., Rubin, K., Pietras, K., & Östman, A. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1456 · Cited by 2,222
Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy
Jain, R. K. (2001) · Nature Medicine · doi:10.1038/nm0901-987 · Cited by 2,184
Gradishar, W. J., Tjulandin, S., Davidson, N., Shaw, H., Desai, N., Bhar, P., Hawkins, M., & O'Shaughnessy, J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.937 · Cited by 2,153
Role of target geometry in phagocytosis
Champion, J. A., & Mitragotri, S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600997103 · Cited by 2,074
Willett, C. G., Boucher, Y., di Tomaso, E., Duda, D. G., Munn, L. L., Tong, R. T., Chung, D. C., Sahani, D. V., Kalva, S. P., Kozin, S. V., et al. (2004) · Nature Medicine · doi:10.1038/nm988 · Cited by 1,966
Nanoparticle Size and Surface Chemistry Determine Serum Protein Adsorption and Macrophage Uptake
Walkey, C. D., Olsen, J. B., Guo, H., Emili, A., & Chan, W. C. W. (2012) · Journal of the American Chemical Society · doi:10.1021/ja2084338 · Cited by 1,926
Rational design of cationic lipids for siRNA delivery
Semple, S. C., Akinc, A., Chen, J., Sandhu, A. P., Mui, B. L., Cho, C. K., Sah, D. W. Y., Stebbing, D., Crosley, E. J., Yaworski, E., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1602 · Cited by 1,822
O’Brien, M. E. R., Wigler, N., Inbar, M., Rosso, R., Grischke, E., Santoro, A., Catane, R., Kieback, D. G., Tomczak, P., Ackland, S. P., et al. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh097 · Cited by 1,738
Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size.
Yuan, F., Dellian, M., Fukumura, D., Leunig, M., Berk, D. A., Torchilin, V. P., & Jain, R. K. (1995) · PubMed · Cited by 1,711
Pharmacokinetics of Pegylated Liposomal Doxorubicin: Review of Animal and Human Studies
Gabizon, A., Shmeeda, H., & Barenholz, Y. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342050-00002 · Cited by 1,634
PEGylated nanoparticles for biological and pharmaceutical applications
Otsuka, H., Nagasaki, Y., & Kataoka, K. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00226-0 · Cited by 1,588
Pharmacokinetics and Biodistribution of Nanoparticles
Li, S.-D., & Huang, L. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800049w · Cited by 1,568
Self-citationMediating Tumor Targeting Efficiency of Nanoparticles Through Design
Perrault, S. D., Walkey, C., Jennings, T., Fischer, H. C., & Chan, W. C. W. (2009) · Nano Letters · doi:10.1021/nl900031y · Cited by 1,513
Prabhakar, U., Maeda, H., Jain, R. K., Sevick-Muraca, E. M., Zamboni, W., Farokhzad, O. C., Barry, S. T., Gabizon, A., Grodzinski, P., & Blakey, D. C. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4561 · Cited by 1,485
Determinants of tumor blood flow: a review.
Jain, R. K. (1988) · PubMed · Cited by 1,379
Transport of molecules in the tumor interstitium: a review.
Jain, R. K. (1987) · PubMed · Cited by 1,378
Drug targeting to tumors: Principles, pitfalls and (pre-) clinical progress
Lammers, T., Kiessling, F., Hennink, W. E., & Storm, G. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.09.063 · Cited by 1,324
Optimizing Liposomes for Delivery of Chemotherapeutic Agents to Solid Tumors
Drummond, D. C., Meyer, O., Hong, K., Kirpotin, D. B., & Papahadjopoulos, D. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01426-1 · Cited by 1,263
Gordon, A. N., Fleagle, J. T., Guthrie, D., Parkin, D. E., Gore, M. E., & Lacave, A. J. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.14.3312 · Cited by 1,211
Tong, R. T., Boucher, Y., Kozin, S. V., Winkler, F., Hicklin, D. J., & Jain, R. K. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0074 · Cited by 1,189
Cellular Uptake, Intracellular Trafficking, and Cytotoxicity of Nanomaterials
Zhao, F., Zhao, Y., Liu, Y., Chang, X., Chen, C., & Zhao, Y. (2011) · Small · doi:10.1002/smll.201100001 · Cited by 1,175
Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation
Winkler, F., Kozin, S. V., Tong, R. T., Chae, S.-S., Booth, M. F., Garkavtsev, I., Xu, L., Hicklin, D. J., Fukumura, D., di Tomaso, E., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.10.011 · Cited by 1,170
Role of extracellular matrix assembly in interstitial transport in solid tumors.
Netti, P. A., Berk, D. A., Swartz, M. A., Grodzinsky, A. J., & Jain, R. K. (2000) · PubMed · Cited by 1,165
Hrkach, J., Von Hoff, D., Ali, M. M., Andrianova, E., Auer, J., Campbell, T., De Witt, D., Figa, M., Figueiredo, M., Horhota, A., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003651 · Cited by 1,147
Kirpotin, D. B., Drummond, D. C., Shao, Y., Shalaby, M. R., Hong, K., Nielsen, U. B., Marks, J. D., Benz, C. C., & Park, J. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4199 · Cited by 1,125
Von Hoff, D. D., Ramanathan, R. K., Borad, M. J., Laheru, D. A., Smith, L. S., Wood, T. E., Korn, R. L., Desai, N., Trieu, V., Iglesias, J. L., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.36.5742 · Cited by 1,044
Xiao, K., Li, Y., Luo, J., Lee, J. S., Xiao, W., Gonik, A. M., Agarwal, R. G., & Lam, K. S. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.01.021 · Cited by 1,039
The effect of the shape of mesoporous silica nanoparticles on cellular uptake and cell function
Huang, X., Teng, X., Chen, D., Tang, F., & He, J. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2009.09.060 · Cited by 1,002
Minimal "Self" Peptides That Inhibit Phagocytic Clearance and Enhance Delivery of Nanoparticles
Rodriguez, P. L., Harada, T., Christian, D. A., Pantano, D. A., Tsai, R. K., & Discher, D. E. (2013) · Science · doi:10.1126/science.1229568 · Cited by 985
Targeting nanoparticles to cancer
Wang, M., & Thanou, M. (2010) · Pharmacological Research · doi:10.1016/j.phrs.2010.03.005 · Cited by 931
Maeda, H., Sawa, T., & Konno, T. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00309-1 · Cited by 925
Poly(2‐oxazoline)s: A Polymer Class with Numerous Potential Applications
Hoogenboom, R. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200901607 · Cited by 889
Cancer cells compress intratumour vessels
Padera, T. P., Stoll, B. R., Tooredman, J. B., Capen, D., Tomaso, E. D., & Jain, R. K. (2004) · Nature · doi:10.1038/427695a · Cited by 857
Bartlett, D. W., Su, H., Hildebrandt, I. J., Weber, W. A., & Davis, M. E. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707461104 · Cited by 803
Ronnov-Jessen, L., Petersen, O. W., & Bissell, M. J. (1996) · Physiological Reviews · doi:10.1152/physrev.1996.76.1.69 · Cited by 793
Detailed Identification of Plasma Proteins Adsorbed on Copolymer Nanoparticles
Cedervall, T., Lynch, I., Foy, M., Berggård, T., Donnelly, S. C., Cagney, G., Linse, S., & Dawson, K. A. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200700465 · Cited by 777
Stimuli-responsive polymers: Biomedical applications and challenges for clinical translation
Hoffman, A. S. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.11.004 · Cited by 759
Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles
Choi, C. H. J., Alabi, C. A., Webster, P., & Davis, M. E. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914140107 · Cited by 699
Albumin-bound formulation of paclitaxel (Abraxane® ABI-007) in the treatment of breast cancer
Tomao, S. (2009) · International Journal of Nanomedicine · doi:10.2147/ijn.s3061 · Cited by 695
Hurwitz, H. I., Fehrenbacher, L., Hainsworth, J. D., Heim, W., Berlin, J., Holmgren, E., Hambleton, J., Novotny, W. F., & Kabbinavar, F. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.10.017 · Cited by 688
Detailed Identification of Plasma Proteins Adsorbed on Copolymer Nanoparticles
Cedervall, T., Lynch, I., Foy, M., Berggård, T., Donnelly, S. C., Cagney, G., Linse, S., & Dawson, K. A. (2007) · Angewandte Chemie · doi:10.1002/ange.200700465 · Cited by 655
Northfelt, D. W., Dezube, B. J., Thommes, J. A., Miller, B. J., Fischl, M. A., Friedman-Kien, A., Kaplan, L. D., Du Mond, C., Mamelok, R. D., & Henry, D. H. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.7.2445 · Cited by 649
Lipid-based Nanoparticles for Nucleic Acid Delivery
Li, W., & Szoka, F. C. (2007) · Pharmaceutical Research · doi:10.1007/s11095-006-9180-5 · Cited by 641
Microvascular permeability of normal and neoplastic tissues
Gerlowski, L. E., & Jain, R. K. (1986) · Microvascular Research · doi:10.1016/0026-2862(86)90018-x · Cited by 622
Shape Induced Inhibition of Phagocytosis of Polymer Particles
Champion, J. A., & Mitragotri, S. (2009) · Pharmaceutical Research · doi:10.1007/s11095-008-9626-z · Cited by 617
Chung, T.-H., Wu, S.-H., Yao, M., Lu, C.-W., Lin, Y.-S., Hung, Y., Mou, C.-Y., Chen, Y.-C., & Huang, D.-M. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.03.006 · Cited by 617
Jain, R. K., Tong, R. T., & Munn, L. L. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4102 · Cited by 612
Complement activation-related pseudoallergy: A new class of drug-induced acute immune toxicity
Szebeni, J. (2005) · Toxicology · doi:10.1016/j.tox.2005.07.023 · Cited by 611
Andresen, T. L., Jensen, S. S., & Jørgensen, K. (2005) · Progress in Lipid Research · doi:10.1016/j.plipres.2004.12.001 · Cited by 580
Pharmacokinetics of stealth versus conventional liposomes: effect of dose
Allen, T. M., & Hansen, C. (1991) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(91)90201-i · Cited by 579
Harrington, K. J., Mohammadtaghi, S., Uster, P. S., Glass, D. M., Peters, A. M., Vile, R. G., & Stewart, J. S. W. (2001) · PubMed · Cited by 575
Needham, D., & Dewhirst, M. W. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00233-2 · Cited by 570
Hamaguchi, T., Matsumura, Y., Suzuki, M., Shimizu, K., Goda, R., Nakamura, I., Nakatomi, I., Yokoyama, M., Kataoka, K., & Kakizoe, T. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602479 · Cited by 565
Stealth nanoparticles: High density but sheddable PEG is a key for tumor targeting
Li, S.-D., & Huang, L. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.03.016 · Cited by 562
Self-citationTransport of macromolecules across microvascular walls: the two-pore theory
Rippe, B., & Haraldsson, B. (1994) · Physiological Reviews · doi:10.1152/physrev.1994.74.1.163 · Cited by 560
Magnetic Iron Oxide Nanoworms for Tumor Targeting and Imaging
Park, J., von Maltzahn, G., Zhang, L., Schwartz, M. P., Ruoslahti, E., Bhatia, S. N., & Sailor, M. J. (2008) · Advanced Materials · doi:10.1002/adma.200800004 · Cited by 557
Diffusion and Convection in Collagen Gels: Implications for Transport in the Tumor Interstitium
Ramanujan, S., Pluen, A., McKee, T. D., Brown, E. B., Boucher, Y., & Jain, R. K. (2002) · Biophysical Journal · doi:10.1016/s0006-3495(02)73933-7 · Cited by 552
Immunomicelles: Targeted pharmaceutical carriers for poorly soluble drugs
Torchilin, V. P., Lukyanov, A. N., Gao, Z., & Papahadjopoulos-Sternberg, B. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0931428100 · Cited by 538
Zhu, L., Kate, P., & Torchilin, V. P. (2012) · ACS Nano · doi:10.1021/nn300524f · Cited by 489
Nanoparticles evading the reticuloendothelial system: Role of the supported bilayer
Li, S.-D., & Huang, L. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2009.06.022 · Cited by 486
Self-citationChanan-Khan, A., Szebeni, J., Savay, S., Liebes, L., Rafique, N. M., Alving, C. R., & Muggia, F. M. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg374 · Cited by 479
More Effective Nanomedicines through Particle Design
Wang, J., Byrne, J. D., Napier, M. E., & DeSimone, J. M. (2011) · Small · doi:10.1002/smll.201100442 · Cited by 466
Liu, D., Mori, A., & Huang, L. (1992) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(92)90136-a · Cited by 463
Chonn, A., Semple, S. C., & Cullis, P. R. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)37026-7 · Cited by 460
Pietras, K., Östman, A., SJÖQUIST, M., Buchdunger, E., Reed, R. K., Heldin, C., & Rubin, K. (2001) · PubMed · Cited by 450
Stylianopoulos, T., Poh, M.-Z., Insin, N., Bawendi, M. G., Fukumura, D., Munn, L. L., & Jain, R. K. (2010) · Biophysical Journal · doi:10.1016/j.bpj.2010.06.016 · Cited by 443
Determination of Doxorubicin Levels in Whole Tumor and Tumor Nuclei in Murine Breast Cancer Tumors
Laginha, K. M., Verwoert, S., Charrois, G. J. R., & Allen, T. M. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0343 · Cited by 441
Gill, P. S., Wernz, J., Scadden, D. T., Cohen, P., Mukwaya, G. M., von Roenn, J. H., Jacobs, M., Kempin, S., Silverberg, I., Gonzales, G., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.8.2353 · Cited by 438
Polymer-drug conjugates: Recent development in clinical oncology
Li, C., & Wallace, S. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.11.009 · Cited by 436
Fang, C., Shi, B., Pei, Y.-Y., Hong, M.-H., Wu, J., & Chen, H.-Z. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.08.002 · Cited by 424
Barz, M., Luxenhofer, R., Zentel, R., & Vicent, M. J. (2011) · Polymer Chemistry · doi:10.1039/c0py00406e · Cited by 418
Kano, M. R., Bae, Y., Iwata, C., Morishita, Y., Yashiro, M., Oka, M., Fujii, T., Komuro, A., Kiyono, K., Kaminishi, M., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611660104 · Cited by 410
Semple, S. C., Chonn, A., & Cullis, P. R. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00128-2 · Cited by 402
Cairns, R., Papandreou, I., & Denko, N. (2006) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0002 · Cited by 370
A novel siRNA-lipoplex technology for RNA interference in the mouse vascular endothelium
Santel, A., Aleku, M., Keil, O., Endruschat, J., Esche, V, Fisch, G., Dames, S., Löffler, K., Fechtner, M., Arnold, W., et al. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302777 · Cited by 368
Nanoparticles with decreasing surface hydrophobicities: influence on plasma protein adsorption
Gessner, A., Waicz, R., Lieske, A., Paulke, B.-R., Mäder, K., & Müller, R. H. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00432-9 · Cited by 358
Gessner, A., Lieske, A., Paulke, B. R., & Müller, R. H. (2002) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(02)00081-4 · Cited by 356
Lee, H., Fonge, H., Hoang, B., Reilly, R. M., & Allen, C. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100038h · Cited by 349
Dos Santos, N., Allen, C., Doppen, A.-M., Anantha, M., Cox, K. A. K., Gallagher, R. C., Karlsson, G., Edwards, K., Kenner, G., Samuels, L., et al. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.12.013 · Cited by 341
Crosasso, P., Ceruti, M., Brusa, P., Arpicco, S., Dosio, F., & Cattel, L. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00166-2 · Cited by 338
Effect of antivascular endothelial growth factor treatment on the intratumoral uptake of CPT-11
Wildiers, H., Guetens, G., De Boeck, G., Verbeken, E., Landuyt, B., Landuyt, W., de Bruijn, E. A., & van Oosterom, A. T. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601005 · Cited by 334
Tumor-targeted Delivery of siRNA by Self-assembled Nanoparticles
Li, S.-D., Chen, Y.-C., Hackett, M. J., & Huang, L. (2008) · Molecular Therapy · doi:10.1038/sj.mt.6300323 · Cited by 333
Self-citationLevchenko, T. S., Rammohan, R., Lukyanov, A. N., Whiteman, K. R., & Torchilin, V. P. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00129-1 · Cited by 332
Triple negative breast cancer: unmet medical needs
Pal, S. K., Childs, B. H., & Pegram, M. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1293-1 · Cited by 322
Polyester-based micelles and nanoparticles for the parenteral delivery of taxanes
Gaucher, G., Marchessault, R. H., & Leroux, J.-C. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.11.012 · Cited by 315
Selective Filtering of Particles by the Extracellular Matrix: An Electrostatic Bandpass
Lieleg, O., Baumgärtel, R. M., & Bausch, A. R. (2009) · Biophysical Journal · doi:10.1016/j.bpj.2009.07.009 · Cited by 304
Nyman, D. W., Campbell, K. J., Hersh, E., Long, K., Richardson, K., Trieu, V., Desai, N., Hawkins, M. J., & Von Hoff, D. D. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2004.00.6148 · Cited by 286
Targeting the prostate for destruction through a vascular address
Arap, W., Haedicke, W., Bernasconi, M., Kain, R., Rajotte, D., Krajewski, S., Ellerby, H. M., Bredesen, D. E., Pasqualini, R., & Ruoslahti, E. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241655998 · Cited by 285
Judge, A., McClintock, K., Phelps, J. R., & MacLachlan, I. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2005.09.014 · Cited by 280
The Role of the Sinus Wall in the Passage of Erythrocytes Through the Spleen
Chen, L.-T., & Weiss, L. (1973) · Blood · doi:10.1182/blood.v41.4.529.529 · Cited by 269
Senior, J., Crawley, J. C. W., & Gregoriadis, G. (1985) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(85)90174-6 · Cited by 253
(1992) · PubMed · Cited by 252
Functional groups on polystyrene model nanoparticles: Influence on protein adsorption
Gessner, A., Lieske, A., Paulke, B., & Müller, R. H. (2003) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.10371 · Cited by 239
Konno, T., Maeda, H., Iwai, K., Maki, S., Tashiro, S., Uchida, M., & Miyauchi, Y. (1984) · Cancer · doi:10.1002/1097-0142(19841201)54:11<2367::aid-cncr2820541111>3.0.co;2-f · Cited by 233
Steric Stabilization of Fusogenic Liposomes by a Low-pH Sensitive PEG−Diortho Ester−Lipid Conjugate
Guo, X., & Szoka, F. C. (2001) · Bioconjugate Chemistry · doi:10.1021/bc000110v · Cited by 232
Nagayama, S., Ogawara, K.-I., Fukuoka, Y., Higaki, K., & Kimura, T. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.04.036 · Cited by 225
Hybrid PET-optical imaging using targeted probes
Nahrendorf, M., Keliher, E., Marinelli, B., Waterman, P., Feruglio, P. F., Fexon, L., Pivovarov, M., Swirski, F. K., Pittet, M. J., Vinegoni, C., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0915163107 · Cited by 222
Fang, J., Sawa, T., & Maeda, H. (2005) · Advances in Experimental Medicine and Biology · doi:10.1007/0-306-47932-x_2 · Cited by 221
Tagami, T., Foltz, W. D., Ernsting, M. J., Lee, C. M., Tannock, I. F., May, J. P., & Li, S.-D. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.05.029 · Cited by 213
Self-citationIn vivo targeting of B-cell lymphoma with glycan ligands of CD22
Chen, W. C., Completo, G. C., Sigal, D. S., Crocker, P. R., Saven, A., & Paulson, J. C. (2010) · Blood · doi:10.1182/blood-2009-12-257386 · Cited by 203
Zhang, K., Fang, H., Chen, Z., Taylor, J.-S. A., & Wooley, K. L. (2008) · Bioconjugate Chemistry · doi:10.1021/bc800160b · Cited by 202
Claasen, H. H. V. R., Kluin, P. M., & Fleuren, G. J. (1992) · PubMed · Cited by 201
Pun, S. H., Tack, F., Bellocq, N. C., Cheng, J., Grubbs, B. H., Jensen, G. S., Davis, M. E., Brewster, M., Janicot, M., Janssens, B., et al. (2004) · Cancer Biology & Therapy · doi:10.4161/cbt.3.7.918 · Cited by 201
Interstitial fluid pressure in breast cancer, benign breast conditions, and breast parenchyma
Nathanson, S. D., & Nelson, L. (1994) · Annals of Surgical Oncology · doi:10.1007/bf03187139 · Cited by 197
Implications of pharmacokinetic behavior of lipoplex for its inflammatory toxicity
ZHANG, J., LIU, F., & HUANG, L. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.12.004 · Cited by 195
Harrington, K. J., Lewanski, C. R., Northcote, A. D., Whittaker, J., Wellbank, H., Vile, R. G., Peters, A. M., & Stewart, J. S. W. (2001) · Annals of Oncology · doi:10.1023/a:1011199028318 · Cited by 182
Seynhaeve, A. L. B., Hoving, S., Schipper, D., Vermeulen, C. E., aan de Wiel-Ambagtsheer, G., van Tiel, S. T., Eggermont, A. M. M., & ten Hagen, T. L. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1599 · Cited by 173
Osaka, T., Nakanishi, T., Shanmugam, S., Takahama, S., & Zhang, H. (2009) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2009.03.004 · Cited by 166
Tagami, T., Ernsting, M. J., & Li, S.-D. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.02.009 · Cited by 166
Self-citation(1993) · PubMed · Cited by 166
Davies, C. D. L., Lundstrøm, L. M., Frengen, J., Eikenes, L., Bruland, Ø. S., Kaalhus, O., Hjelstuen, M. H. B., & Brekken, C. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-0576 · Cited by 163
MAEDA, H., Takeshita, J., & Kanamaru, R. (1979) · International journal of peptide & protein research · doi:10.1111/j.1399-3011.1979.tb01730.x · Cited by 159
Kale, A. A., & Torchilin, V. P. (2007) · Journal of Drug Targeting · doi:10.1080/10611860701498203 · Cited by 159
Moghimi, S. M., & Patel, H. M. (1988) · FEBS Letters · doi:10.1016/0014-5793(88)81372-3 · Cited by 156
Tagami, T., Ernsting, M. J., & Li, S. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.05.020 · Cited by 156
Self-citationCapture of Stealth Nanoparticles by the Body’s Defences
Moghimi, S. M., & Hunter, A. C. (2001) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v18.i6.30 · Cited by 154
Lim, W., Tan, E. H., Toh, C., Hee, S. W., Leong, S. S., Ang, P., Wong, N. S., & Chowbay, B. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp315 · Cited by 146
Nomura, T., Koreeda, N., Yamashita, F., Takakura, Y., & Hashida, M. (1998) · Pharmaceutical Research · doi:10.1023/a:1011921324952 · Cited by 135
In Vivo Distribution of Polymeric Nanoparticles at the Whole-Body, Tumor, and Cellular Levels
Lee, H., Hoang, B., Fonge, H., Reilly, R. M., & Allen, C. J. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0068-z · Cited by 132
Murakami, M., Ernsting, M. J., Undzys, E., Holwell, N., Foltz, W. D., & Li, S. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0062 · Cited by 131
Self-citationKoshkaryev, A., Sawant, R. R., Deshpande, M., & Torchilin, V. P. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.08.009 · Cited by 122
Role of cancer-associated fibroblasts in breast cancer development and prognosis
Aboussekhra, A. (2011) · The International Journal of Developmental Biology · doi:10.1387/ijdb.113362aa · Cited by 121
Systemic Delivery of siRNA via LCP Nanoparticle Efficiently Inhibits Lung Metastasis
Yang, Y., Li, J., Liu, F., & Huang, L. (2011) · Molecular Therapy · doi:10.1038/mt.2011.270 · Cited by 121
Al-Sarireh, B., & Eremin, O. (2000) · PubMed · Cited by 119
Factors affecting the pharmacokinetics of pegylated liposomal doxorubicin in patients
La-Beck, N. M., Zamboni, B. A., Gabizón, A., Schmeeda, H., Amantea, M., Gehrig, P. A., & Zamboni, W. C. (2011) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-011-1664-2 · Cited by 118
Ishida, T., Ichikawa, T., Ichihara, M., Sadzuka, Y., & Kiwada, H. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.12.011 · Cited by 117
McNeeley, K. M., Annapragada, A., & Bellamkonda, R. V. (2007) · Nanotechnology · doi:10.1088/0957-4484/18/38/385101 · Cited by 117
Factors Affecting Drug and Gene Delivery: Effects of Interaction with Blood Components
Hashida, M., Opanasopit, P., & Nishikawa, M. (2002) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v19.i3.10 · Cited by 115
Li, C., Newman, R. A., Wu, Q.-P., Shi, K., Chen, W., Hutto, T. Y., Kan, Z., Brannan, M. D., Charnsangavej, C., & Wallace, S. (2000) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800000168 · Cited by 114
Ernsting, M. J., Tang, W.-L., MacCallum, N., & Li, S. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.10.061 · Cited by 113
Self-citationGabizón, A., Isacson, R., Rosengarten, O. S., Tzemach, D., Shmeeda, H., & Sapir, R. (2007) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-007-0525-5 · Cited by 110
Boddy, A. V., Plummer, E. R., Todd, R., Sludden, J., Griffin, M., Robson, L., Cassidy, J., Bissett, D., Bernareggi, A., Verrill, M. W., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0803 · Cited by 108
Jain, R., Gutierrez, J., Narang, J., Scarpace, L. M., Schultz, L. R., Lemke, N. W., Patel, S. C., Mikkelsen, T., & Rock, J. P. (2010) · American Journal of Neuroradiology · doi:10.3174/ajnr.a2280 · Cited by 107
Low-pH-Sensitive PEG-Stabilized Plasmid−Lipid Nanoparticles: Preparation and Characterization
Choi, J. S., MacKay, J. A., & Szoka, F. C. (2003) · Bioconjugate Chemistry · doi:10.1021/bc025625w · Cited by 107
Liposome-encapsulated actin–hemoglobin (LEAcHb) artificial blood substitutes
Li, S., Nickels, J. D., & Palmer, A. F. (2004) · Biomaterials · doi:10.1016/j.biomaterials.2004.09.015 · Cited by 104
Self-citationShaffer, S. A., Baker-Lee, C., Kennedy, J., Lai, M. S., de Vries, P. W., Buhler, K. R., & Singer, J. W. (2006) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-006-0296-4 · Cited by 104
Alizadeh, D., Zhang, L., Hwang, J., Schluep, T., & Badie, B. (2009) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2009.10.001 · Cited by 103
Li, C., Shi, K., Wu, Q., Tansey, W., Hunter, N. R., Buchmiller, L., Milas, L., Charnsangavej, C., & Wallace, S. (2000) · PubMed · Cited by 102
Nanoparticle Albumin–Bound Paclitaxel for Metastatic Breast Cancer
Harries, M., Ellis, P., & Harper, P. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.08.002 · Cited by 100
Imaging Nanoprobe for Prediction of Outcome of Nanoparticle Chemotherapy by Using Mammography
Karathanasis, E., Suryanarayanan, S., Balusu, S. R., McNeeley, K. M., Sechopoulos, I., Karellas, A., Annapragada, A., & Bellamkonda, R. V. (2009) · Radiology · doi:10.1148/radiol.2502080801 · Cited by 97
Anscher, M. S., Chen, L., Rabbani, Z. N., Kang, S., Larrier, N., Huang, H., Samulski, T. V., Dewhirst, M. W., Brizel, D. M., Folz, R. J., et al. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.01.040 · Cited by 96
Tagami, T., May, J. P., Ernsting, M. J., & Li, S. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.023 · Cited by 90
Self-citationLetchford, K., Liggins, R., Wasan, K. M., & Burt, H. M. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.08.003 · Cited by 90
Measurement of macromolecular diffusion coefficients in human tumors
Brown, E. B., Boucher, Y., Nasser, S. M., & Jain, R. K. (2004) · Microvascular Research · doi:10.1016/j.mvr.2004.02.001 · Cited by 78
Effect of liposomalization on the antitumor activity, side-effects and tissue distribution of CPT-11
Sadzuka, Y., Hirotsu, S., & Hirota, S. (1998) · Cancer Letters · doi:10.1016/s0304-3835(98)00031-7 · Cited by 74
Interpatient Pharmacokinetic and Pharmacodynamic Variability of Carrier-Mediated Anticancer Agents
Caron, W. P., Song, G. J., Kumar, P., Rawal, S., & Zamboni, W. C. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.12 · Cited by 68
Increasing tumor uptake of anticancer drugs with imatinib
Pietras, K. (2004) · Seminars in Oncology · doi:10.1053/j.seminoncol.2004.03.036 · Cited by 61
Tanaka, S., Akaike, T., Wu, J., Fang, J. Q., Sawa, T., Ogawa, M., Beppu, T., & Maeda, H. (2003) · Journal of drug targeting · doi:10.1080/1061186031000086072 · Cited by 59
Tumor-targeted drug delivery using MR-contrasted docetaxel – Carboxymethylcellulose nanoparticles
Ernsting, M. J., Foltz, W. D., Undzys, E., Tagami, T., & Li, S. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.02.019 · Cited by 57
Self-citationSeki, T., Carroll, F., Illingworth, S., Green, N., Cawood, R., Bachtarzi, H., Šubr, V., Fisher, K. D., & Seymour, L. W. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.08.022 · Cited by 53
Experimental studies on the uptake and retention of labelled proteins in a rat tumour
Peterson, H.-I., & Appelgren, K. L. (1973) · European Journal of Cancer (1965) · doi:10.1016/0014-2964(73)90142-4 · Cited by 51
Dynamic fluorescence imaging for multiparametric measurement of tumor vasculature
Choi, M., Choi, K., Ryu, S., Lee, J., & Choi, C. (2011) · Journal of Biomedical Optics · doi:10.1117/1.3562956 · Cited by 50
Magnetic Resonance Imaging of Therapy-Induced Necrosis Using Gadolinium-Chelated Polyglutamic Acids
Jackson, E. F., Esparza‐Coss, E., Wen, X., Ng, C. S., Daniel, S. L., Price, R. E., Rivera, B., Charnsangavej, C., Gelovani, J. G., & Li, C. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.01.011 · Cited by 40
Immune responses of therapeutic lipid nanoparticles
Chen, W. C., May, J. P., & Li, S. (2012) · Nanotechnology Reviews · doi:10.1515/ntrev-2012-0040 · Cited by 31
Self-citation“Diffusible‐PEG‐Lipid Stabilized Plasmid Lipid Particles”
MacLachlan, I., & Cullis, P. R. (2005) · Advances in genetics · doi:10.1016/s0065-2660(05)53006-2 · Cited by 28
Zamboni, W. C., Eiseman, J. L., Strychor, S., Rice, P. M., Joseph, E., Zamboni, B. A., Donnelly, M. K., Shurer, J., Parise, R. A., Tonda, M. E., et al. (2010) · Journal of Liposome Research · doi:10.3109/08982101003754385 · Cited by 28
Vascular proteomic mapping in vivo
Simonson, A. B., & Schnitzer, J. E. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02551.x · Cited by 27
Wu, Ramanathan, R. K., Zamboni, Strychor, Ramalingam, Edwards, R. P., Friedland, Stoller, Belani, C. P., Bang, Y., et al. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s35751 · Cited by 8
Cited by
Progress and challenges towards targeted delivery of cancer therapeutics
Rosenblum, D., Joshi, N., Tao, W., Karp, J. M., & Peer, D. (2018) · Nature Communications · doi:10.1038/s41467-018-03705-y · Cited by 2,220
Diverse Applications of Nanomedicine
Pelaz, B., Alexiou, C., Alvarez-Puebla, R. A., Alves, F., Andrews, A. M., Ashraf, S., Balogh, L. P., Ballerini, L., Bestetti, A., Brendel, C., et al. (2017) · ACS Nano · doi:10.1021/acsnano.6b06040 · Cited by 1,350
Therapeutic Nanoparticles and Their Targeted Delivery Applications
Yetisgin, A. A., Cetinel, S., Zuvin, M., Kosar, A., & Kutlu, O. (2020) · Molecules · doi:10.3390/molecules25092193 · Cited by 1,080
Xu, M., Qi, Y., Liu, G., Song, Y., Jiang, X., & Du, B. (2023) · ACS Nano · doi:10.1021/acsnano.3c05853 · Cited by 632
Lipid nanoparticles enabling gene therapies: from concepts to clinical utility
Kulkarni, J. A., Cullis, P. R., & van der Meel, R. (2018) · Nucleic Acid Therapeutics · doi:10.1089/nat.2018.0721 · Cited by 592
Metadata
- Authors
- Ernsting, M. J., Murakami, M., Roy, A., & Li, S.-D.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2013-12
- Volume
- 172
- Issue
- 3
- Pages
- 782-794
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W1963675633
- Cited by
- 1,012
- References
- 177
- FWCI
- 22.04
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.